IFG WEALTH MANAGEMENT FORUMTHE PREMIER EVENT FOR NORTH AMERICAN FAMILY OFFICESOctober 24-25, 2011, Ritz-Carlton, Amelia Is...
IFG WEALTH MANAGEMENT FORUMTHE PREMIER EVENT FOR NORTH AMERICAN FAMILY OFFICESOctober 24-25, 2011, Ritz-Carlton, Amelia Is...
Upcoming SlideShare
Loading in...5
×

Bay City Capital: How to Profit from the Life Sciences Industry - Carl Goldfisher, Bay City Capital

123

Published on

Carl Goldfischer, Managing Director at Bay City Capital, shares his expertise on why private wealth managers should consider investing in life sciences.

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
123
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Bay City Capital: How to Profit from the Life Sciences Industry - Carl Goldfisher, Bay City Capital"

  1. 1. IFG WEALTH MANAGEMENT FORUMTHE PREMIER EVENT FOR NORTH AMERICAN FAMILY OFFICESOctober 24-25, 2011, Ritz-Carlton, Amelia Island, FLwww.ifgwealthmanagement.comBay City Capital –How to Profit from the Carl Goldfischer, ManagingLife Sciences Industry Director at Bay City Capital, shares his expertise on why private wealth managers should consider investing in life sciences. Bay City Capital will be attending theFOR IMMEDIATE RELEASE upcoming IFG Wealth Management Forum 2011.The life sciences industry holds great promise for IFG – What should investors take into account,the future, but patience and having a broad view in order to successfully invest in this industry?of the industry are key. Private wealth managersmust diversify investments across the industry Carl Goldfischer – It is important for wealthand on products at various stages of their managers to invest with groups that are able tolifecycle. Life sciences assets may not reap diversify their portfolios into different types ofinstant results nor be suitable for portfolios with companies and products at various stages of theshort-term liquidity needs, but they are worth the product lifecycle, from discovery towait. Ahead of the IFG Wealth Management commercialization. Many venture firms areForum 2011 on Amelia Island, Florida, October confined to a strategy of solely investing in early-24-25, Carl Goldfischer, Managing Director at Bay stage companies. We do our fair share ofCity Capital, highlights the real value of life investing in early-stage innovation; however,sciences assets in an investment portfolio. during times of market fluctuation, such as that which we have experienced over the last fewIFG – How does the life sciences industry years, our investment strategy allows our teamcompare with other industries? the freedom to invest in later-stage companies at early-stage valuations. We also make a point ofCarl Goldfischer – Returns from life sciences investing solely in companies where ourassets are attractive over the long-term. Large operational, financial, and scientific expertise canpharmaceutical companies have a significant benefit the management team and create valuenumber of blockbuster drugs coming off patent in over the long term.the next few years and are therefore under anenormous amount of pressure to fill their IFG – What asset allocation works best?pipelines. Combined with the fact that they havedrastically cut funding for their own internal Carl Goldfischer – To succeed in this industry, it isresearch and development projects, they are now important to maintain a broad view. It is difficultforced to buy innovation externally. to predict which drugs will ultimately succeed, www.internationalforumgroup.com
  2. 2. IFG WEALTH MANAGEMENT FORUMTHE PREMIER EVENT FOR NORTH AMERICAN FAMILY OFFICESOctober 24-25, 2011, Ritz-Carlton, Amelia Island, FLwww.ifgwealthmanagement.comtherefore we pursue opportunities across the various life markets is five times that of the United States. Asset managerssciences sectors – biopharmaceuticals, drug discovery, medical who understand the life sciences industry and developingdevices, diagnostics and tools – and across different stages of markets, and are able to be selective with their investments, willproduct development. be successful.It is also important to maintain a global perspective. Emerging IFG – Any final thoughts?markets, such as China, provide a significant investmentopportunity in the life sciences. The Chinese government has Carl Goldfischer – Investing in life sciences requires patience. But,launched a $125 billion initiative to overhaul its healthcare asset managers that use a diversified approach can providesystem. The expectations for growth in life sciences in emerging attractive returns for investors.Salpi Balian, Press Manager – IFG, pressifg@ifgemea.comThe IFG Wealth Management Forum 2011IFG’s Wealth Management Forum 2011 will take place at the Ritz Carlton, Amelia Island, Florida, October 24-25, 2011, and provides aunique platform for investment decision makers from single and multi-family offices to engage in vibrant benchmarking sessions andgain practical solutions and best practices to achieve optimal portfolio returns.For more information please send an email to pressifg@ifgemea.com or visit the event website at www.ifgwealthmanagement.comThe International Forum GroupInternational Forum Group is a world-leading business information company, organizing exclusive, invitation-only gatherings ofbusiness leaders across multiple industry sectors.Providing a platform for senior executives to build mutually beneficial business partnerships, International Forum Group hasdesigned an unparalleled system for matching the core buying needs of the world’s largest organizations with the best solutionsavailable in the global marketplace. Empowering all our clients with the knowledge they need to lead in their respective fields is afundamental goal of all our forums.For more information, please visit: www.internationalforumgroup.comBay City CapitalBay City Capital is a life sciences venture capital firm investing in opportunities across various life sciences sectors in companies at allstages of development. Established in 1997, the firm has managed seven venture capital funds representing $1.6 billion in capitalcommitments. Bay City Capital has invested in over 90 companies to date and is actively seeking new investment opportunities.More information: www.baycitycapital.comAll rights reserved. The above content may be republished or reproduced. Please notify prior to usage at pressifg@ifgemea.com www.internationalforumgroup.com

×